Bacterial outer membrane vesicle-based cancer nanovaccines

Tumor vaccines, a type of personalized tumor immunotherapy, have developed rapidly in recent decades. These vaccines evoke tumor antigen-specific T cells to achieve immune recognition and killing of tumor cells. Because the immunogenicity of tumor antigens alone is insufficient, immune adjuvants and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xiaoyu, Feng, Qingqing, Wang, Jing, Zhao, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500226/
https://www.ncbi.nlm.nih.gov/pubmed/36172794
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500226/
https://www.ncbi.nlm.nih.gov/pubmed/36172794
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0452

Ejemplares similares